- Home
- VNCE vs OTLK Comparison
VNCE vs OTLK Comparison
Compare VNCE & OTLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNCE
- OTLK
- Stock Information
- Founded
- VNCE 2002
- OTLK 2010
- Country
- VNCE United States
- OTLK United States
- Employees
- VNCE N/A
- OTLK N/A
- Industry
- VNCE Clothing/Shoe/Accessory Stores
- OTLK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- VNCE Consumer Discretionary
- OTLK Health Care
- Exchange
- VNCE Nasdaq
- OTLK Nasdaq
- Market Cap
- VNCE 37.1M
- OTLK 42.8M
- IPO Year
- VNCE 2013
- OTLK 2016
- Fundamental
- Price
- VNCE $2.91
- OTLK $1.48
- Analyst Decision
- VNCE Strong Buy
- OTLK Buy
- Analyst Count
- VNCE 4
- OTLK 5
- Target Price
- VNCE $4.63
- OTLK $5.25
- AVG Volume (30 Days)
- VNCE 434.1K
- OTLK 2.5M
- Earning Date
- VNCE 12-09-2025
- OTLK 08-14-2025
- Dividend Yield
- VNCE N/A
- OTLK N/A
- EPS Growth
- VNCE N/A
- OTLK N/A
- EPS
- VNCE N/A
- OTLK N/A
- Revenue
- VNCE $291,286,000.00
- OTLK $1,505,322.00
- Revenue This Year
- VNCE $1.48
- OTLK N/A
- Revenue Next Year
- VNCE $4.92
- OTLK $313.69
- P/E Ratio
- VNCE N/A
- OTLK N/A
- Revenue Growth
- VNCE N/A
- OTLK N/A
- 52 Week Low
- VNCE $1.02
- OTLK $0.79
- 52 Week High
- VNCE $6.89
- OTLK $6.98
- Technical
- Relative Strength Index (RSI)
- VNCE 52.21
- OTLK 60.29
- Support Level
- VNCE $2.62
- OTLK $1.27
- Resistance Level
- VNCE $3.21
- OTLK $1.54
- Average True Range (ATR)
- VNCE 0.26
- OTLK 0.11
- MACD
- VNCE -0.07
- OTLK 0.05
- Stochastic Oscillator
- VNCE 38.20
- OTLK 82.02
About VNCE Vince Holding Corp.
Vince Holding Corp is a fashion brand that is engaged in wholesale and retail delivery of luxury essentials like women's and men's apparel, women's and men's footwear, and handbags. Its offers women's collections of luxurious cashmere sweaters and silk blouses, leather and suede leggings and jackets, dresses, denim, pants, tanks and t-shirts, and a growing assortment of outerwear. It focuses on developing an elevated collection of Vince apparel and accessories to serve the luxurious need of the customer. The company manages its business in three segments namely Vince Wholesale, Vince Direct-to-consumer, and Rebecca Taylor and Parker segment. It operates its e-commerce business through its website. Majority of its revenue generated from Vince Wholesale segment.
About OTLK Outlook Therapeutics Inc.
Outlook Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.